Maravai LifeSciences (MRVI) EBITDA (2020 - 2025)
Maravai LifeSciences (MRVI) EBITDA from Mar 31, 2020 to Sep 30, 2025. The TTM Maravai LifeSciences (MRVI) EBITDA is -$171M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Maravai LifeSciences (MRVI) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -7.89% |
Annual EBITDA change of Maravai LifeSciences (MRVI)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$139M | -35.35% |
| 2024 | -$215M | +1045.39% |
| 2023 | -$19M | -103.22% |
| 2022 | $582M | +3.69% |
| 2021 | $561M | +347.06% |
| 2020 | $126M | +351.44% |
| 2019 | $28M | N/A |
Comparison Maravai LifeSciences (MRVI) five years EBITDA CAGR with competitors
Maravai LifeSciences (MRVI) five years EBITDA CAGR is 52.37%.